Academic Journals Database
Disseminating quality controlled scientific knowledge

Search Articles for "gemcitabine"

ADD TO MY LIST
 
Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma

Author(s): Nicolas Williet | Olivier Dubreuil | Tarek Boussaha | Isabelle Trouilloud | Bruno Landi | Martin Housset | Muriel Botti | Philippe Rougier | Jacques Belghiti | Julien Taieb
Safety and Pharmacokinetics of Motesanib in Combination with Panitumumab and Gemcitabine-Cisplatin in Patients with Advanced Cancer

Author(s): Howard Burris | Joe Stephenson | Gregory A. Otterson | Mark Stein | Jesse McGreivy | Yu-Nien Sun | Megan Ingram | Yining Ye | Lee S. Schwartzberg
Gemcitabine and carboplatin combination in patients with advanced and locally advanced stage non-small cell lung cancer

Author(s): Nevzat ÖZTÜRK | Ahmet Emin ERBAYCU | Mehmet GÜLPEK | Fevziye TUKSAVUL | Özgür USLU | Salih Zeki GÜÇLÜ
Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes

Author(s): G. Perrone | S. Morini | D. Santini | C. Rabitti | B. Vincenzi | R. Alloni | A. Antinori | P. Magistrelli | R. Lai | C. Cass | J. R. Mackey | R. Coppola | G. Tonini | A. Onetti Muda
Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer

Author(s): Jill P Smith | Sandra I Bingaman | David T Mauger | et al
Erlotinib in the treatment of advanced pancreatic cancer

Author(s): Robin K Kelley | Andrew H Ko
Treatment of Pancreatic Cancer: What Can We Really Predict Today?

Author(s): Jean-Baptiste Bachet | Raphael Marechal | Jean-Luc Van Laethem
Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer

Author(s): Awasthi Niranjan | Kirane Amanda | Schwarz Margaret | Toombs Jason | Brekken Rolf | Schwarz Roderich
Hepatic arterial infusion of gemcitabine-oxaliplatin in a large metastasis from colon cancer

Author(s): Boris Guiu, Julie Vincent, Séverine Guiu, Sylvain Ladoire, Pablo Ortega-Deballon, Jean-Pierre Cercueil, Bruno Chauffert, François Ghiringhelli
Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers

Author(s): Minoru Tada, Yousuke Nakai, Takashi Sasaki, Tsuyoshi Hamada, Rie Nagano, Dai Mohri, Koji Miyabayashi, Keisuke Yamamoto, Hirofumi Kogure, Kazumichi Kawakubo, Yukiko Ito, Natsuyo Yamamoto, Naoki Sasahira, Kenji Hirano, Hideaki Ijichi, Keishuke Tateishi, Hiroyuki Isayama, Masao Omata, Kazuhiko Koike
Comparison of Intra-Arterial Chemotherapy with Gemcitabine or Floxuridine Followed by TACE with Oxaliplatine

Author(s): Hao Ming-Zhi | Chen Qiang | Lin Hai-Lan | Wu Hui | Chen Qi-Zhong | Li Jian-Cheng | Zheng Jian-Xiong | Ye Yun-Bin
Complete response to FOLFOX4 therapy in a patient with advanced urothelial cancer: a case report

Author(s): Seo Yu | Kim Se | Kim Hyun | Kim Chan | Park Seong | Koh Eun | Hong Dae
Current Surgical Aspects of Palliative Treatment for Unresectable Pancreatic Cancer

Author(s): Konstantinos Karapanos | Iakovos N. Nomikos
The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine

Author(s): Hornick John | Xu Jinbin | Vangveravong Suwanna | Tu Zhude | Mitchem Jonathan | Spitzer Dirk | Goedegebuure Peter | Mach Robert | Hawkins William
Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib

Author(s): Christina Wich, Abbas Agaimy, Deike Strobel, Thaddäus Till Wissniowski, Arndt Hartmann, Matthias Ocker
The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer

Author(s): Kenneth J. O’Byrne | Martin P. Barr | Steven G. Gray
Repetitive response to gemcitabine that led to curative resection in cholangiocarcinoma

Author(s): Seong Hun Kim, In Hee Kim, Sang Wook Kim, Seung-Ok Lee
DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells

Author(s): Unger Florian | Klasen Hermann | Tchartchian Garri | de Wilde Rudy | Witte Irene
Toxicity risk of non-target organs at risk receiving low-dose radiation: case report

Author(s): Shueng Pei-Wei | Lin Shih-Chiang | Chang Hou-Tai | Chong Ngot-Swan | Chen Yu-Jen | Wang Li-Ying | Hsieh Yen-Ping | Hsieh Chen-Hsi
Rapid Determination of Gemcitabine and Its Metabolite in Human Plasma by LC-MSMS through Micro Protein Precipitation with Minimum Matrix Effect

Author(s): Ling-Zhi Wang | Wei-Peng Yong | Ross-A. Soo | Soo-Chin Lee | Richie Soong | How- Sung Lee | Boon-Cher Goh
A meta Analysis of Gemcitabine plus Platinum Chemotherapy Compared with Single-agent Chemotherapy in the Treatment of Non-small Cell Lung Cancer

Author(s): Yunjiu GOU | Lingjuan ZHANG | Qimei YANG | Rongfang ZHANG | Huiling GUO | Lei JIANG | Kehu YANG | Jinhui TIAN
Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer

Author(s): Nakata Bunzo | Amano Ryosuke | Nakao Shigetomi | Tamura Tatsuro | Shinto Osamu | Hirakawa Toshiki | Okita Yoshihiro | Yamada Nobuya | Hirakawa Kosei
RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy

Author(s): Dong Song | Guo Ai-Lin | Chen Zhi-Hong | Wang Zhen | Zhang Xu-Chao | Huang Ying | Xie Zhi | Yan Hong-Hong | Cheng Hua | Wu Yi-Long
Gemcitabine and treatment of diffuse large B-cell lymphoma in relapsed or refractory elderly patients: A prospective randomized trial in Algeria

Author(s): Aribi Mourad | Mesli Naima | Remla Nesrine | Sari Badr-Eddine | Taleb Abdesselam | Touhami Hadj | Bekadja Mohamed-Amine | Zouaoui-Benhadji Zahia | Bouzid Kamel | Meguenni Kaoual
Vitamin D in combination cancer treatment

Author(s): Yingyu Ma, Donald L. Trump, Candace S. Johnson
TGFBI expression is associated with a better response to chemotherapy in NSCLC

Author(s): Irigoyen Marta | Pajares María | Agorreta Jackeline | Ponz-Sarvisé Mariano | Salvo Elisabeth | Lozano María | Pío Ruben | Gil-Bazo Ignacio | Rouzaut Ana
Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy

Author(s): Cottin Sylvine | Ghani Karim | de Campos-Lima Pedro | Caruso Manuel
Copy number variation and cytidine analogue cytotoxicity: A genome-wide association approach

Author(s): Kalari Krishna | Hebbring Scott | Chai High | Li Liang | Kocher Jean-Pierre | Wang Liewei | Weinshilboum Richard
Non-small cell lung cancer presenting with choroidal metastasis as first sign and showing good response to chemotherapy alone: a case report

Author(s): Singh Abhishek | Singh Parul | Sahni Kamal | Shukla Preety | Shukla Vikas | Pant Nirdosh
Genotoxicity and Cytotoxicity of the Anticancer Drugs Gemcitabine and Cisplatin, Separately and in Combination: in vivo Studies

Author(s): Magdy S. Aly | Mohamad B. Ashour | Soheir M. El Nahas | Mona A. F. Abo Zeid
Activity of combined gemcitabine therapy on treatment of planocellular carcinoma: A pilot study

Author(s): Šćepanović Danijela S. | Bajić Nada | Babić Jovan
Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma

Author(s): Wolfgang Hagmann | Ralf Faissner | Martina Schnölzer | Matthias Löhr | Ralf Jesnowski
Small molecule tyrosine kinase inhibitors in pancreatic cancer

Author(s): Sachin Gupta | Bassel F El-Rayes
Gemcitabine and taxanes in metastatic breast cancer: a systematic review

Author(s): Vinay Gudena | Alberto J Montero | Stefan Glück
Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer

Author(s): Francesco Di Costanzo | Silvia Gasperoni | Virginia Rotella | Federica Di Costanzo
Cancer Stem-Like Cells Enriched in Panc-1 Spheres Possess Increased Migration Ability and Resistance to Gemcitabine

Author(s): Tao Yin | Hongji Wei | Shanmiao Gou | Pengfei Shi | Zhiyong Yang | Gang Zhao | Chunyou Wang
A Randomized Study of Gemcitabine plus Cisplatin and Vinorelbine plus Cisplatin in Patients with Advanced Non-small-cell Lung Cancer

Author(s): John Wen-Cheng Chang | Thomas Chang-Yao Tsao | Cheng-Ta Yang | Meng-Chih Lin | Yun-Chung Cheung | Chung-Chi Liaw | Chih-Hung Chen
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas

Author(s): Pignochino Ymera | Sarotto Ivana | Peraldo-Neia Caterina | Penachioni Junia | Cavalloni Giuliana | Migliardi Giorgia | Casorzo Laura | Chiorino Giovanna | Risio Mauro | Bardelli Alberto | Aglietta Massimo | Leone Francesco
Postoperative recurrence of an IPMN of the pancreas with a fistula to the stomach

Author(s): Masaya Uesato | Yoshihiro Nabeya | Shinichi Miyazaki | Taito Aoki | Takashi Akai | Kiyohiko Shuto | Tohru Tanizawa | Masaru Miyazaki | Hisahiro Matsubara
TTF-1 is useful for primary site determination in duodenal metastasis

Author(s): Tomofumi Miura | Yuichi Shimaoka | Junichiro Nakamura | Satoshi Yamada | Tsutomu Miura | Masahiko Yanagi | Kazuhiro Sato | Hiroyuki Usuda | Iwao Emura | Toru Takahashi
Treatment of biliary tract cancer with NVP-AEW541: Mechanisms of action and resistance

Author(s): Samuel Wolf, Jana Lorenz, Joachim Mössner, Marcus Wiedmann
Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer

Author(s): Soley Bayraktar, Ulas Darda Bayraktar, Caio Max Rocha-Lima
Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells

Author(s): Benjaporn Buranrat, Auemduan Prawan, Upa Kukongviriyapan, Sarinya Kongpetch, Veerapol Kukongviriyapan
Phase II Study of a Biweekly Regimen of Vinorelbine and Cisplatin in Advanced Non-small Cell Lung Cancer

Author(s): Chih-Hung Chen | Chih-Ming Lin | Kuo-Chin Kao | John WC Chang | Thomas Chang-Yao Tsao
Poorly differentiated endocrine carcinoma of the pancreas responded to gemcitabine: Case report

Author(s): Shoichi Nakazuru, Toshiyuki Yoshio, Shigeki Suemura, Mari Itoh, Manabu Araki, Chiaki Yoshioka, Makiyo Ohta, Yuka Sueyoshi, Takashi Ohta, Hiroko Hasegawa, Kaori Morita, Takashi Toyama, Noriyoshi Kuzushita, Yoshinori Kodama, Masayuki Mano, Eiji Mita
Smoking and Prognostic Factors in an Observational Setting in Patients with Advanced Non-Small Cell Lung Carcinoma

Author(s): Chien-Te Li, Magdalena Marek, Salih Z Guclu, Younseup Kim, Mohamed Meshref, Shukui Qin, Zbigniew Kadziola, Kurt Krejcy, Sedat Altug
Randomize Trial of Cisplatin plus Gemcitabine with either Sorafenib or Placebo as First-line Therapy for Non-small Cell Lung Cancer

Author(s): Yan WANG | Lin WANG | Yutao LIU | Shufei YU | Xiangru ZHANG | Yuankai SHI | Yan SUN
A case of advanced intrahepatic cholangiocarcinoma successfully treated with chemosensitivity test-guided systemic chemotherapy

Author(s): Kazumichi Abe, Takeru Wakatsuki, Fumiko Katsushima, Kyoko Monoe, Yukiko Kanno, Atsushi Takahashi, Junko Yokokawa, Hiromasa Ohira
Persistence of side population cells with high drug efflux capacity in pancreatic cancer

Author(s): Jing Zhou, Chun-You Wang, Tao Liu, Bin Wu, Feng Zhou, Jiong-Xin Xiong, He-Shui Wu, Jing Tao, Gang Zhao, Ming Yang, Shan-Miao Gou
Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: Seven cases

Author(s): Kiminori Uka, Hiroshi Aikata, Shintaro Takaki, Tomokazu Kawaoka, Hiromi Saneto, Daiki Miki, Shoichi Takahashi, Naoyuki Toyota, Katsuhide Ito, Kazuaki Chayama
Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy

Author(s): Atsushi Sofuni, Takao Itoi, Fumihide Itokawa, Takayoshi Tsuchiya, Toshio Kurihara, Kentaro Ishii, Syujiro Tsuji, Nobuhito Ikeuchi, Fuminori Moriyasu
Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors

Author(s): Martin Haefner, Thilo Bluethner, Manuel Niederhagen, Christian Moebius, Christian Wittekind, Joachim Mossner, Karel Caca, Marcus Wiedmann
Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer

Author(s): Hisato Igarashi, Tetsuhide Ito, Ken Kawabe, Terumasa Hisano, Yoshiyuki Arita, Toyoma Kaku, Ryoichi Takayanagi
Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma

Author(s): Tian-Jie Qin, Xin-Han Zhao, Jun Yun, Ling-Xiao Zhang, Zhi-Ping Ruan, Bo-Rong Pan
A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma

Author(s): Hu Jing | Zhao Gang | Wang Hong-Xia | Tang Lei | Xu Ying-Chun | Ma Yue | Zhang Feng-Chun
CXCL12 expression by healthy and malignant ovarian epithelial cells

Author(s): Machelon Véronique | Gaudin Françoise | Camilleri-Broët Sophie | Nasreddine Salam | Bouchet-Delbos Laurence | Pujade-Lauraine Eric | Alexandre Jerôme | Gladieff Laurence | Arenzana-Seisdedos Fernando | Emilie Dominique | Prévot Sophie | Broët Philippe | Balabanian Karl
Targeted Therapy for Biliary Tract Cancer

Author(s): Junji Furuse | Takuji Okusaka
Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway

Author(s): Wei-Tian Wei, Hui Chen, Zhao-Hong Wang, Zhong-Lin Ni, Hai-Bin Liu, Hong-Fei Tong, Hong-Chun Guo, Dian-Lei Liu, Sheng-Zhang Lin
Gemcitabine in Bone Sarcoma Resistant to Doxorubicin-BasedChemotherapy

Author(s): Ofer Merimsky | Isaac Meller | Yehuda Kollender | Josephine Issakov | Gideon Flusser | Moshe Inbar
Phase II Trial of Improved Regimen with Gemcitabine in Patients 
with Advanced Non-small Cell Lung Cancer

Author(s): Lulu MIAO | Yun FAN | Zhiyu HUANG | Nengming LIN | Lvhong LUO | Haifeng YU
Molecular interactions between anticancer drugs and iodinated contrast media: An in vitro spectroscopic study

Author(s): Shunro Matsumoto | Hiro Kiyosue | Seiji Ujiie | Takeshi Yoshimi | Hiromu Mori | Ryoichi Ishii | Norio Hongo | Kenji Matsumura
Organ Preservation in Bilharzial Bladder Cancer in Egypt: Single Institutional Experience

Author(s): Mohamed Ahmed Abo-Almagd | Ahmed Mokhtar | Ashraf Elyamany | Farouk Morad Amr | Mohamed Abdel Aboziada | Hamza Abbas | Mohamed Abdallah El-Gmal | Mostafa Elsayed Abdalwanis
Organ Preservation in Bilharzial Bladder Cancer in Egypt: Single Institutional Experience

Author(s): Mohamed Ahmed Abo-Almagd | Ahmed Mokhtar | Ashraf Elyamany | Farouk Morad Amr | Mohamed Abdel Aboziada | Hamza Abbas | Mohamed Abdallah El-Gmal | Mostafa Elsayed Abdalwanis
Concurrent chemoradiation with weekly Gemcitabine and Cisplatin in locally advanced cervical cancer

Author(s): Amouzegar Hashemi F | Hamed Akbari E | Kalaghchi B | Esmati E
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)

Author(s): Heinrich Stefan | Pestalozzi Bernhard | Lesurtel Mickael | Berrevoet Frederik | Laurent Stéphanie | Delpero Jean-Robert | Raoul Jean-Luc | Bachellier Phillippe | Dufour Patrick | Moehler Markus | Weber Achim | Lang Hauke | Rogiers Xavier | Clavien Pierre-Alain
Chemotherapy in advanced bladder cancer: current status and future

Author(s): Ismaili Nabil | Amzerin Mounia | Flechon Aude
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

Author(s): Barni Sandro | Labianca Roberto | Agnelli Giancarlo | Bonizzoni Erminio | Verso Melina | Mandalà Mario | Brighenti Matteo | Petrelli Fausto | Bianchini Carlo | Perrone Tania | Gasparini Giampietro
Gemcitabine- Carboplatin Combination therapy for recurrent ovarian cancer: a prospective study

Author(s): Modares Gilani M | Behtash N | Karimi Zarchi M | Samizadeh Z | Ghaemmaghami F | Mousavi A
PHASE II STUDY OF GEMCITABINE AND CISPLATIN IN ADVANCED NON-SMALL CELL LUNG CANCER

Author(s): M. Hoseinzadeh Mollayosefy | M. Iravani | A. Ghavamzadeh | G. Toogheh K. Alimoghadam
Phase II study of Gemcitabine and Cisplatin Regimen in Advanced Non-Small Cell Lung Cancer (NSCLC).

Author(s): Hoseinzadeh Mollayosefy M | Iravani M | Ghavamzadeh A | Toogheh Gh | Alimoghaddam K
Targeting the Large Subunit of Human Ribonucleotide Reductase for Cancer Chemotherapy

Author(s): Sanath R. Wijerathna | Md. Faiz Ahmad | Hai Xu | James W. Fairman | Andrew Zhang | Prem Singh Kaushal | Qun Wan | Jianying Kiser | Chris G. Dealwis
Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro

Author(s): Yu-Mei Gu | Yi-Hui Ma | Wu-Gan Zhao | Jie Chen
Effectiveness of two different HDR brachytherapy regimens with the same BED value in cervical cancer

Author(s): Kamlesh Passi | Than S Kehwar | Meenakshi Mittal | Bikramjit Singh | Rajesh Vashistha | Sureshchandra J Gupta | JV Yakhmi
Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study

Author(s): Kotasek Dusan | Tebbutt Niall | Desai Jayesh | Welch Stephen | Siu Lillian | McCoy Sheryl | Sun Yu-Nien | Johnson Jessica | Adewoye Adeboye | Price Timothy
Primary leiomyosarcoma of the seminal vesicle: Case report and review of the literature

Author(s): Cauvin Cécile | Moureau-Zabotto Laurence | Chetaille Bruno | Hilgers Werner | Denoux Yves | Jacquemier Jocelyne | Guiramand Jérôme | Sarran Anthony | Bertucci François
Gemcitabine in elderly patients with advanced pancreatic cancer

Author(s): Olivia Hentic | Chantal Dreyer | Vinciane Rebours | Magaly Zappa | Philippe Lévy | Eric Raymond | Philippe Ruszniewski | Pascal Hammel
Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt

Author(s): Chandra Bartholomeusz, Fumiyuki Yamasaki, Hitomi Saso, Kaoru Kurisu, Gabriel N. Hortobagyi, Naoto T. Ueno
Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report

Author(s): Syrios John | Kechagias Georgios | Xynos Ioannis | Gamaletsou Maria | Papageorgiou Aristea | Agrogiannis George | Tsavaris Nicolas
Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy

Author(s): Lister Adam | Nedjadi Taoufik | Kitteringham Neil | Campbell Fiona | Costello Eithne | Lloyd Bryony | Copple Ian | Williams Samantha | Owen Andrew | Neoptolemos John | Goldring Chris | Park B Kevin
Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer

Author(s): Nordentoft Iver | Dyrskjøt Lars | Bødker Julie | Wild Peter | Hartmann Arndt | Bertz Simone | Lehmann Jan | Ørntoft Torben | Birkenkamp-Demtroder Karin
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy

Author(s): Alagkiozidis Ioannis | Facciabene Andrea | Tsiatas Marinos | Carpenito Carmine | Benencia Fabian | Adams Sarah | Jonak Zdenka | June Carl | Powell Daniel | Coukos George
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Author(s): Davis Jeremy | Pandalai Prakash | Ripley R Taylor | Langan Russell | Steinberg Seth | Walker Melissa | Toomey Mary | Levy Elliot | Avital Itzhak
Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells

Author(s): Alli Elizabeth | Sharma Vandana | Hartman Anne-Renee | Lin Patrick | McPherson Lisa | Ford James
Henoch Schönlein purpura associated with pulmonary adenocarcinoma

Author(s): Mifune Daiki | Watanabe Satoshi | Kondo Rie | Wada Yoko | Moriyama Hiroshi | Kagamu Hiroshi | Yoshizawa Hirohisa | Tetsuka Takafumi | Matsuyama Asako | Ito Kaoru | Narita Ichiei
A docking model of human ribonucleotide reductase with flavin and phenosafranine

Author(s): Panneerselvam Lakshmi Priya | Piramanayagam Shanmughavel
An oral fluoropyrimidine agent S-1 induced interstitial lung disease: A case report

Author(s): Hiromichi Yamane | Masahide Kinugawa | Shigeki Umemura | Yasuhiro Shiote | Kenichiro Kudo | Toshimitsu Suwaki | Haruhito Kamei | Nagio Takigawa | Katsuyuki Kiura
Palliation with Previously Gemcitabine in Patients with Advanced Pancreatic Cancer Treated with the Placement of a Covered Metal Biliary Stent

Author(s): D. Xinopoulos | D. Dimitroulopoulos | A. Fotopoulou | D. Korkolis | K. Tsamakidis | D. Kypreos | S. Basioukas | S. Patsavela | A. Loukou | E. Paraskevas
Gemcitabine Treatment in Pancreatic Cancer – Prognostic Factors and Outcome

Author(s): B. Andersson | Ursula Aho | Marie-Louise Pendse | J. Nilsson | B. Tingstedt | R. Andersson
Why do you need a reservation system?      Affiliate Program